Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S4 Y-linked 1 (RPS4Y1) is a protein encoded by the RPS4Y1 gene in humans and is a structural component of the small 40S subunit of cytoplasmic ribosomes, which are essential for catalyzing protein synthesis. RPS4Y1 is one of several isoforms of ribosomal protein S4, unique among ribosomal proteins because it is encoded by more than one gene—RPS4Y1 (Y chromosome), RPS4Y2 (Y chromosome, testis-specific), and RPS4X (X chromosome). The protein participates in RNA binding and assembling the ribosomal machinery for translation. While largely functionally redundant with the X-linked form, RPS4Y1 is retained in the male genome likely for gene dosage compensation. There is suggestive but disputed evidence associating haploinsufficiency of these genes with Turner syndrome. RPS4Y1 does not appear to be a direct therapeutic target, nor are there known drug interactions, biomarker roles, or safety/tolerability issues reported[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S4 Y-linked 1 (RPS4Y1).